Doxepin

Breastfeeding
  • TRADE NAMES: Adapin (LGM Pharma); Alti-Doxepin; Anten; Aponal; Doneurin; Gilex; Mareen; Novo-Doxepin; Silenor (Somaxon); Sinquan (Pfizer); Triadapin
  • INDICATIONS: Mental depression, anxiety, insomnia
  • CLASS: Antidepressant; tricyclic, Muscarinic antagonist
  • HALF-LIFE: 6–8 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alcohol, Amprenavir, Arbutamine, Cholestyramine, Clonidine, CNS depressants, Epinephrine, Formoterol, Guanethidine, Isocarboxazid, Linezolid, MAO inhibitors, Phenelzine, QT prolonging agents, Quinolones, Ramelteon, Selegiline, Sparfloxacin, Sympathomimetics, Tranylcypromine

PREGNANCY CATEGORY: C
pregnancy category is B for topical use

SUICIDALITY AND ANTIDEPRESSANT DRUGS

See full prescribing information for complete boxed warning.

Our database has 42 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
OTHER.


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top